Structure

Physi-Chem Properties

Molecular Weight:  502.37
Volume:  546.548
LogP:  4.75
LogD:  3.802
LogS:  -4.34
# Rotatable Bonds:  7
TPSA:  83.83
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.351
Synthetic Accessibility Score:  5.166
Fsp3:  0.871
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.837
MDCK Permeability:  1.8411048586131074e-05
Pgp-inhibitor:  0.992
Pgp-substrate:  0.006
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.894
30% Bioavailability (F30%):  0.97

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.957
Plasma Protein Binding (PPB):  58.48478698730469%
Volume Distribution (VD):  1.285
Pgp-substrate:  27.176963806152344%

ADMET: Metabolism

CYP1A2-inhibitor:  0.019
CYP1A2-substrate:  0.6
CYP2C19-inhibitor:  0.107
CYP2C19-substrate:  0.881
CYP2C9-inhibitor:  0.13
CYP2C9-substrate:  0.068
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.04
CYP3A4-inhibitor:  0.908
CYP3A4-substrate:  0.891

ADMET: Excretion

Clearance (CL):  9.029
Half-life (T1/2):  0.054

ADMET: Toxicity

hERG Blockers:  0.119
Human Hepatotoxicity (H-HT):  0.343
Drug-inuced Liver Injury (DILI):  0.039
AMES Toxicity:  0.013
Rat Oral Acute Toxicity:  0.966
Maximum Recommended Daily Dose:  0.943
Skin Sensitization:  0.152
Carcinogencity:  0.816
Eye Corrosion:  0.004
Eye Irritation:  0.013
Respiratory Toxicity:  0.981

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC218107

Natural Product ID:  NPC218107
Common Name*:   Garcihombronane B
IUPAC Name:   methyl (E,4R,6R)-6-[(3R,5S,8S,9R,10S,13S,17S)-3,9-dihydroxy-4,4,10,13,17-pentamethyl-1,2,3,5,6,7,8,11,12,16-decahydrocyclopenta[a]phenanthren-17-yl]-4-hydroxy-2-methylhept-2-enoate
Synonyms:  
Standard InCHIKey:  CIVHEWNEBOOQEN-DIBHTQSVSA-N
Standard InCHI:  InChI=1S/C31H50O5/c1-19(26(34)36-8)17-21(32)18-20(2)28(5)13-11-22-23-9-10-24-27(3,4)25(33)12-14-30(24,7)31(23,35)16-15-29(22,28)6/h11,17,20-21,23-25,32-33,35H,9-10,12-16,18H2,1-8H3/b19-17+/t20-,21+,23+,24+,25-,28+,29-,30+,31-/m1/s1
SMILES:  C/C(=C[C@@H](C[C@@H](C)[C@]1(C)CC=C2[C@@H]3CC[C@H]4C(C)(C)[C@@H](CC[C@]4(C)[C@]3(CC[C@@]12C)O)O)O)/C(=O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL512141
PubChem CID:   44559190
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001445] Bile acids, alcohols and derivatives
          • [CHEMONTID:0002194] Hydroxy bile acids, alcohols and derivatives
            • [CHEMONTID:0000516] Dihydroxy bile acids, alcohols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20779 Garcinia hombroniana Species Clusiaceae Eukaryota leaves n.a. n.a. PMID[16124765]
NPO20779 Garcinia hombroniana Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 128.0 ug.mL-1 PMID[476385]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC218107 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.914 High Similarity NPC119562
0.914 High Similarity NPC279410
0.8947 High Similarity NPC190713
0.8936 High Similarity NPC476186
0.8866 High Similarity NPC251680
0.8854 High Similarity NPC99726
0.883 High Similarity NPC476304
0.8776 High Similarity NPC25177
0.8776 High Similarity NPC222875
0.8776 High Similarity NPC295110
0.8776 High Similarity NPC247701
0.8776 High Similarity NPC268829
0.8737 High Similarity NPC57117
0.8723 High Similarity NPC74296
0.8723 High Similarity NPC110923
0.871 High Similarity NPC146554
0.871 High Similarity NPC472240
0.871 High Similarity NPC262858
0.8673 High Similarity NPC470074
0.8654 High Similarity NPC470063
0.8646 High Similarity NPC276110
0.8632 High Similarity NPC38232
0.8632 High Similarity NPC472871
0.8617 High Similarity NPC78973
0.8614 High Similarity NPC220217
0.8614 High Similarity NPC119855
0.86 High Similarity NPC97487
0.86 High Similarity NPC189588
0.86 High Similarity NPC10232
0.86 High Similarity NPC160583
0.86 High Similarity NPC196471
0.86 High Similarity NPC187302
0.86 High Similarity NPC112009
0.86 High Similarity NPC297617
0.8571 High Similarity NPC325229
0.8571 High Similarity NPC92275
0.8571 High Similarity NPC275086
0.8557 High Similarity NPC114743
0.8557 High Similarity NPC195366
0.8542 High Similarity NPC105490
0.8542 High Similarity NPC201725
0.8526 High Similarity NPC234335
0.8526 High Similarity NPC329842
0.8511 High Similarity NPC314727
0.85 High Similarity NPC475038
0.85 High Similarity NPC109195
0.8485 Intermediate Similarity NPC38855
0.8485 Intermediate Similarity NPC201406
0.8485 Intermediate Similarity NPC471041
0.8469 Intermediate Similarity NPC253826
0.8469 Intermediate Similarity NPC141401
0.8469 Intermediate Similarity NPC51499
0.8447 Intermediate Similarity NPC137462
0.8447 Intermediate Similarity NPC304276
0.8438 Intermediate Similarity NPC7349
0.8438 Intermediate Similarity NPC214697
0.8431 Intermediate Similarity NPC186668
0.8421 Intermediate Similarity NPC295668
0.8416 Intermediate Similarity NPC45897
0.8416 Intermediate Similarity NPC171014
0.8416 Intermediate Similarity NPC180204
0.8416 Intermediate Similarity NPC472821
0.84 Intermediate Similarity NPC471412
0.8381 Intermediate Similarity NPC470076
0.8367 Intermediate Similarity NPC234993
0.8367 Intermediate Similarity NPC54248
0.8367 Intermediate Similarity NPC276103
0.8367 Intermediate Similarity NPC134072
0.8352 Intermediate Similarity NPC2524
0.8351 Intermediate Similarity NPC474922
0.8333 Intermediate Similarity NPC472868
0.8333 Intermediate Similarity NPC72845
0.8333 Intermediate Similarity NPC473543
0.8333 Intermediate Similarity NPC177641
0.8333 Intermediate Similarity NPC212948
0.8317 Intermediate Similarity NPC476081
0.8316 Intermediate Similarity NPC474396
0.8316 Intermediate Similarity NPC50488
0.8302 Intermediate Similarity NPC44537
0.83 Intermediate Similarity NPC324841
0.83 Intermediate Similarity NPC471413
0.8298 Intermediate Similarity NPC166857
0.8286 Intermediate Similarity NPC103491
0.8286 Intermediate Similarity NPC12795
0.8283 Intermediate Similarity NPC231751
0.8283 Intermediate Similarity NPC108078
0.8283 Intermediate Similarity NPC320306
0.828 Intermediate Similarity NPC474013
0.8269 Intermediate Similarity NPC88701
0.8269 Intermediate Similarity NPC275539
0.8269 Intermediate Similarity NPC189075
0.8269 Intermediate Similarity NPC275060
0.8265 Intermediate Similarity NPC279974
0.8261 Intermediate Similarity NPC476927
0.8252 Intermediate Similarity NPC295843
0.8252 Intermediate Similarity NPC88349
0.8252 Intermediate Similarity NPC472818
0.8247 Intermediate Similarity NPC205034
0.8247 Intermediate Similarity NPC53555
0.8247 Intermediate Similarity NPC162615
0.8247 Intermediate Similarity NPC152778
0.8242 Intermediate Similarity NPC159148
0.8241 Intermediate Similarity NPC470075
0.8235 Intermediate Similarity NPC120321
0.8235 Intermediate Similarity NPC476237
0.8235 Intermediate Similarity NPC85742
0.8235 Intermediate Similarity NPC473523
0.8235 Intermediate Similarity NPC478057
0.8235 Intermediate Similarity NPC36688
0.8235 Intermediate Similarity NPC95899
0.8229 Intermediate Similarity NPC182136
0.8229 Intermediate Similarity NPC221111
0.8229 Intermediate Similarity NPC302280
0.8229 Intermediate Similarity NPC280149
0.8229 Intermediate Similarity NPC310479
0.8218 Intermediate Similarity NPC11974
0.8218 Intermediate Similarity NPC475617
0.8211 Intermediate Similarity NPC472870
0.8208 Intermediate Similarity NPC255401
0.8208 Intermediate Similarity NPC284162
0.8208 Intermediate Similarity NPC183603
0.82 Intermediate Similarity NPC278673
0.82 Intermediate Similarity NPC57079
0.82 Intermediate Similarity NPC108368
0.8191 Intermediate Similarity NPC175145
0.8191 Intermediate Similarity NPC6391
0.8191 Intermediate Similarity NPC261266
0.8191 Intermediate Similarity NPC474970
0.8191 Intermediate Similarity NPC131813
0.8191 Intermediate Similarity NPC475069
0.819 Intermediate Similarity NPC475030
0.819 Intermediate Similarity NPC75389
0.8182 Intermediate Similarity NPC16967
0.8182 Intermediate Similarity NPC473153
0.8182 Intermediate Similarity NPC235053
0.8173 Intermediate Similarity NPC67321
0.8173 Intermediate Similarity NPC79298
0.8173 Intermediate Similarity NPC472820
0.8173 Intermediate Similarity NPC471205
0.8173 Intermediate Similarity NPC43063
0.8173 Intermediate Similarity NPC110496
0.8173 Intermediate Similarity NPC187435
0.8163 Intermediate Similarity NPC191521
0.8155 Intermediate Similarity NPC472819
0.8144 Intermediate Similarity NPC473675
0.8144 Intermediate Similarity NPC472811
0.8144 Intermediate Similarity NPC477574
0.8137 Intermediate Similarity NPC293753
0.8137 Intermediate Similarity NPC162973
0.8137 Intermediate Similarity NPC475344
0.8137 Intermediate Similarity NPC476471
0.8137 Intermediate Similarity NPC273668
0.8132 Intermediate Similarity NPC281880
0.8125 Intermediate Similarity NPC170633
0.8125 Intermediate Similarity NPC177141
0.8125 Intermediate Similarity NPC246028
0.8119 Intermediate Similarity NPC477968
0.8119 Intermediate Similarity NPC473510
0.8119 Intermediate Similarity NPC472826
0.8119 Intermediate Similarity NPC20113
0.8119 Intermediate Similarity NPC476767
0.8119 Intermediate Similarity NPC161527
0.8119 Intermediate Similarity NPC477972
0.8119 Intermediate Similarity NPC327431
0.8119 Intermediate Similarity NPC219285
0.8119 Intermediate Similarity NPC228251
0.8119 Intermediate Similarity NPC477971
0.8105 Intermediate Similarity NPC149224
0.81 Intermediate Similarity NPC210337
0.81 Intermediate Similarity NPC73911
0.81 Intermediate Similarity NPC477719
0.81 Intermediate Similarity NPC477718
0.8095 Intermediate Similarity NPC475263
0.8095 Intermediate Similarity NPC306265
0.8085 Intermediate Similarity NPC266511
0.8085 Intermediate Similarity NPC274448
0.8085 Intermediate Similarity NPC164424
0.8081 Intermediate Similarity NPC472441
0.8081 Intermediate Similarity NPC476174
0.8081 Intermediate Similarity NPC281134
0.8081 Intermediate Similarity NPC474909
0.8081 Intermediate Similarity NPC271195
0.8077 Intermediate Similarity NPC189863
0.8065 Intermediate Similarity NPC470558
0.8065 Intermediate Similarity NPC79945
0.8061 Intermediate Similarity NPC139692
0.8061 Intermediate Similarity NPC472812
0.8058 Intermediate Similarity NPC474822
0.8058 Intermediate Similarity NPC474124
0.8058 Intermediate Similarity NPC222153
0.8058 Intermediate Similarity NPC471938
0.8058 Intermediate Similarity NPC471208
0.8058 Intermediate Similarity NPC281378
0.8056 Intermediate Similarity NPC122056
0.8056 Intermediate Similarity NPC171126
0.8056 Intermediate Similarity NPC154815
0.8043 Intermediate Similarity NPC170303
0.8039 Intermediate Similarity NPC118174
0.8039 Intermediate Similarity NPC473160
0.8037 Intermediate Similarity NPC475668

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC218107 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8866 High Similarity NPD7640 Approved
0.8866 High Similarity NPD7639 Approved
0.8763 High Similarity NPD7638 Approved
0.8137 Intermediate Similarity NPD7632 Discontinued
0.802 Intermediate Similarity NPD4225 Approved
0.7838 Intermediate Similarity NPD7115 Discovery
0.7742 Intermediate Similarity NPD7525 Registered
0.7611 Intermediate Similarity NPD7328 Approved
0.7611 Intermediate Similarity NPD7327 Approved
0.76 Intermediate Similarity NPD7515 Phase 2
0.7565 Intermediate Similarity NPD8033 Approved
0.7544 Intermediate Similarity NPD7516 Approved
0.7478 Intermediate Similarity NPD8294 Approved
0.7478 Intermediate Similarity NPD8377 Approved
0.7451 Intermediate Similarity NPD7748 Approved
0.7431 Intermediate Similarity NPD6899 Approved
0.7431 Intermediate Similarity NPD6881 Approved
0.7426 Intermediate Similarity NPD6079 Approved
0.7426 Intermediate Similarity NPD7637 Suspended
0.7414 Intermediate Similarity NPD8379 Approved
0.7414 Intermediate Similarity NPD8296 Approved
0.7414 Intermediate Similarity NPD8378 Approved
0.7414 Intermediate Similarity NPD8380 Approved
0.7414 Intermediate Similarity NPD8335 Approved
0.7407 Intermediate Similarity NPD7128 Approved
0.7407 Intermediate Similarity NPD6402 Approved
0.7407 Intermediate Similarity NPD5739 Approved
0.7407 Intermediate Similarity NPD6675 Approved
0.74 Intermediate Similarity NPD6051 Approved
0.74 Intermediate Similarity NPD5328 Approved
0.7374 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD5344 Discontinued
0.7353 Intermediate Similarity NPD6399 Phase 3
0.7347 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD5697 Approved
0.732 Intermediate Similarity NPD6695 Phase 3
0.7311 Intermediate Similarity NPD7507 Approved
0.7297 Intermediate Similarity NPD7290 Approved
0.7297 Intermediate Similarity NPD7102 Approved
0.7297 Intermediate Similarity NPD6883 Approved
0.729 Intermediate Similarity NPD5211 Phase 2
0.7273 Intermediate Similarity NPD3618 Phase 1
0.7273 Intermediate Similarity NPD6011 Approved
0.7273 Intermediate Similarity NPD6686 Approved
0.7273 Intermediate Similarity NPD7320 Approved
0.7265 Intermediate Similarity NPD7503 Approved
0.7257 Intermediate Similarity NPD4632 Approved
0.7245 Intermediate Similarity NPD4786 Approved
0.7245 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD7902 Approved
0.7238 Intermediate Similarity NPD6083 Phase 2
0.7238 Intermediate Similarity NPD6084 Phase 2
0.7232 Intermediate Similarity NPD6617 Approved
0.7232 Intermediate Similarity NPD6869 Approved
0.7232 Intermediate Similarity NPD6650 Approved
0.7232 Intermediate Similarity NPD6847 Approved
0.7232 Intermediate Similarity NPD6649 Approved
0.7232 Intermediate Similarity NPD8130 Phase 1
0.7216 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD6372 Approved
0.7207 Intermediate Similarity NPD6373 Approved
0.7207 Intermediate Similarity NPD6013 Approved
0.7207 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD6012 Approved
0.7207 Intermediate Similarity NPD6014 Approved
0.7204 Intermediate Similarity NPD7339 Approved
0.7204 Intermediate Similarity NPD6942 Approved
0.7188 Intermediate Similarity NPD7332 Phase 2
0.7188 Intermediate Similarity NPD6931 Approved
0.7188 Intermediate Similarity NPD6930 Phase 2
0.7184 Intermediate Similarity NPD4202 Approved
0.7182 Intermediate Similarity NPD5701 Approved
0.7168 Intermediate Similarity NPD8297 Approved
0.7168 Intermediate Similarity NPD6882 Approved
0.7156 Intermediate Similarity NPD5141 Approved
0.7143 Intermediate Similarity NPD5222 Approved
0.7143 Intermediate Similarity NPD5221 Approved
0.7143 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7131 Intermediate Similarity NPD7319 Approved
0.7103 Intermediate Similarity NPD5285 Approved
0.7103 Intermediate Similarity NPD5286 Approved
0.7103 Intermediate Similarity NPD4696 Approved
0.7103 Intermediate Similarity NPD6648 Approved
0.7091 Intermediate Similarity NPD6008 Approved
0.7087 Intermediate Similarity NPD8034 Phase 2
0.7087 Intermediate Similarity NPD8035 Phase 2
0.7083 Intermediate Similarity NPD7645 Phase 2
0.7083 Intermediate Similarity NPD6929 Approved
0.708 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD4755 Approved
0.7075 Intermediate Similarity NPD5173 Approved
0.7069 Intermediate Similarity NPD6009 Approved
0.7041 Intermediate Similarity NPD3667 Approved
0.7037 Intermediate Similarity NPD5223 Approved
0.703 Intermediate Similarity NPD7524 Approved
0.703 Intermediate Similarity NPD7750 Discontinued
0.7018 Intermediate Similarity NPD6053 Discontinued
0.701 Intermediate Similarity NPD7514 Phase 3
0.6991 Remote Similarity NPD5955 Clinical (unspecified phase)
0.699 Remote Similarity NPD5785 Approved
0.6981 Remote Similarity NPD4697 Phase 3
0.6979 Remote Similarity NPD6114 Approved
0.6979 Remote Similarity NPD6115 Approved
0.6979 Remote Similarity NPD7322 Clinical (unspecified phase)
0.6979 Remote Similarity NPD6697 Approved
0.6979 Remote Similarity NPD6118 Approved
0.6972 Remote Similarity NPD4633 Approved
0.6972 Remote Similarity NPD5224 Approved
0.6972 Remote Similarity NPD5225 Approved
0.6972 Remote Similarity NPD5226 Approved
0.6961 Remote Similarity NPD5737 Approved
0.6961 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6961 Remote Similarity NPD6672 Approved
0.6952 Remote Similarity NPD7900 Approved
0.6952 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6947 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6944 Remote Similarity NPD4700 Approved
0.6939 Remote Similarity NPD6898 Phase 1
0.6931 Remote Similarity NPD7521 Approved
0.6931 Remote Similarity NPD7334 Approved
0.6931 Remote Similarity NPD6684 Approved
0.6931 Remote Similarity NPD6409 Approved
0.6931 Remote Similarity NPD7146 Approved
0.6931 Remote Similarity NPD5330 Approved
0.6923 Remote Similarity NPD5693 Phase 1
0.6915 Remote Similarity NPD6924 Approved
0.6915 Remote Similarity NPD6926 Approved
0.6909 Remote Similarity NPD5174 Approved
0.6909 Remote Similarity NPD5175 Approved
0.6907 Remote Similarity NPD4195 Approved
0.69 Remote Similarity NPD6400 Clinical (unspecified phase)
0.69 Remote Similarity NPD3665 Phase 1
0.69 Remote Similarity NPD3133 Approved
0.69 Remote Similarity NPD3666 Approved
0.6893 Remote Similarity NPD4753 Phase 2
0.6891 Remote Similarity NPD6319 Approved
0.6887 Remote Similarity NPD5695 Phase 3
0.6887 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6925 Approved
0.6875 Remote Similarity NPD5776 Phase 2
0.6864 Remote Similarity NPD6335 Approved
0.686 Remote Similarity NPD7604 Phase 2
0.6852 Remote Similarity NPD5696 Approved
0.6842 Remote Similarity NPD6371 Approved
0.6842 Remote Similarity NPD4634 Approved
0.6838 Remote Similarity NPD6274 Approved
0.6838 Remote Similarity NPD6868 Approved
0.6837 Remote Similarity NPD7509 Discontinued
0.6833 Remote Similarity NPD5983 Phase 2
0.6832 Remote Similarity NPD1694 Approved
0.6832 Remote Similarity NPD6893 Approved
0.6807 Remote Similarity NPD7101 Approved
0.6807 Remote Similarity NPD7100 Approved
0.6804 Remote Similarity NPD7145 Approved
0.6803 Remote Similarity NPD7492 Approved
0.68 Remote Similarity NPD5362 Discontinued
0.68 Remote Similarity NPD4788 Approved
0.6796 Remote Similarity NPD6903 Approved
0.678 Remote Similarity NPD6317 Approved
0.6774 Remote Similarity NPD7736 Approved
0.6771 Remote Similarity NPD6933 Approved
0.6771 Remote Similarity NPD6117 Approved
0.6768 Remote Similarity NPD6902 Approved
0.6765 Remote Similarity NPD4623 Approved
0.6765 Remote Similarity NPD4519 Discontinued
0.6765 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6762 Remote Similarity NPD7087 Discontinued
0.6757 Remote Similarity NPD4754 Approved
0.675 Remote Similarity NPD6054 Approved
0.6748 Remote Similarity NPD6336 Discontinued
0.6748 Remote Similarity NPD6616 Approved
0.6731 Remote Similarity NPD6904 Approved
0.6731 Remote Similarity NPD6673 Approved
0.6731 Remote Similarity NPD6080 Approved
0.6729 Remote Similarity NPD5210 Approved
0.6729 Remote Similarity NPD4629 Approved
0.6726 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6723 Remote Similarity NPD6313 Approved
0.6723 Remote Similarity NPD6314 Approved
0.6701 Remote Similarity NPD6116 Phase 1
0.6701 Remote Similarity NPD6932 Approved
0.67 Remote Similarity NPD4221 Approved
0.67 Remote Similarity NPD4223 Phase 3
0.6699 Remote Similarity NPD3573 Approved
0.6698 Remote Similarity NPD5779 Approved
0.6698 Remote Similarity NPD5778 Approved
0.6697 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6694 Remote Similarity NPD7078 Approved
0.6667 Remote Similarity NPD4729 Approved
0.6667 Remote Similarity NPD4730 Approved
0.6667 Remote Similarity NPD1696 Phase 3
0.6667 Remote Similarity NPD5128 Approved
0.6667 Remote Similarity NPD8133 Approved
0.6667 Remote Similarity NPD7838 Discovery
0.6667 Remote Similarity NPD5329 Approved
0.6639 Remote Similarity NPD6370 Approved
0.6637 Remote Similarity NPD4768 Approved
0.6637 Remote Similarity NPD4767 Approved
0.6633 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6612 Remote Similarity NPD6059 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data